Success Metrics

Clinical Success Rate
70.6%

Based on 24 completed trials

Completion Rate
71%(24/34)
Active Trials
15(23%)
Results Posted
21%(5 trials)
Terminated
10(15%)

Phase Distribution

Ph phase_2
5
8%
Ph not_applicable
32
49%
Ph phase_1
6
9%

Phase Distribution

6

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution43 total trials
Phase 1Safety & dosage
6(14.0%)
Phase 2Efficacy & side effects
5(11.6%)
N/ANon-phased studies
32(74.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

70.6%

24 of 34 finished

Non-Completion Rate

29.4%

10 ended early

Currently Active

15

trials recruiting

Total Trials

65

all time

Status Distribution
Active(19)
Completed(24)
Terminated(10)
Other(12)

Detailed Status

Completed24
unknown12
Recruiting12
Terminated10
Not yet recruiting3
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
65
Active
15
Success Rate
70.6%
Most Advanced
Phase 2

Trials by Phase

Phase 16 (14.0%)
Phase 25 (11.6%)
N/A32 (74.4%)

Trials by Status

terminated1015%
unknown1218%
enrolling_by_invitation12%
completed2437%
not_yet_recruiting35%
recruiting1218%
active_not_recruiting35%

Recent Activity

Clinical Trials (65)

Showing 20 of 65 trialsScroll for more
NCT05553899Not Applicable

Utility of PET-MRI in Surveillance of Paediatric Brain Tumours

Recruiting
NCT03176836Not Applicable

Li-Fraumeni Syndrome Imaging Study

Enrolling By Invitation
NCT07523997

Imaging of Endometriosis With Total-body PET-CT (PET-Endo)

Not Yet Recruiting
NCT06305390Phase 2

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

Recruiting
NCT03606070Not Applicable

Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study

Terminated
NCT04668872

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Recruiting
NCT06940427Phase 2

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Recruiting
NCT04454450Not Applicable

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

Active Not Recruiting
NCT05796102Not Applicable

PET-MRI Esophagus Feasibility Study

Recruiting
NCT03549559Not Applicable

Imaging Histone Deacetylase in the Heart

Recruiting
NCT07010484

Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica

Recruiting
NCT06171659

FDG PET/MR Imaging of Peripheral Pain Generators

Recruiting
NCT05390814Phase 1

[18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma

Completed
NCT04826211Not Applicable

Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI

Completed
NCT06947759

Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma

Not Yet Recruiting
NCT05954507Not Applicable

Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis

Recruiting
NCT04829643Not Applicable

Axillary Staging in Early Breast Cancer: SNB vs PET/MRI

Completed
NCT06856096Not Applicable

PET/MRI Artificial Intelligence Reconstruction Algorithm AIR Recon DL Image Quality Evaluation and Clinical Study

Active Not Recruiting
NCT01839747Not Applicable

Evaluation of PET/MRI in Children With Cancer

Completed
NCT04097535

Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI

Completed

Drug Details

Intervention Type
RADIATION
Total Trials
65